← Eichor
Study identifier: NCT03308916 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers

Condition: Liver Diseases, Alcoholic · Fibrosis  ·  Sponsor: Maja Thiele

PhaseNA
Planned participants6500
Who can joinAll sexes, 30 Years to 75 Years
Healthy volunteersNo

About this study

Prospective screening study at Odense University Hospital to assess the effect of transient elastography and other serum and imaging markers of liver fibrosis to detect advanced fibrosis (Kleiner Fibrosis score F3-F4) in patients at risk of non-alcoholic fatty liver disease, alcoholic fatty liver disease, with a control group of participants recruited from the general population.

This description comes directly from the study's public registry record.

Talk to the study team

Maja Thiele, MD, PhD, Professor  ·  +4524998068  ·  maja.thiele@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Gastroenterology and Hepatology, Odense University HospitalOdense, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03308916